NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

By McCauley John A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 389-407

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of a Potent and Highly Selective Small Molecule Muscarinic Acetylcholine Receptor Subtype I (mAChR 1 or M1) Antagonist In Vitro and In Vivo Probe

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1217-1226

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

In vivo and in vitro effects of muscarinic receptor antagonists on contractions and release of [ 3 H]acetylcholine in the rabbit urinary bladder

By Tobin G.   Sjogren C.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

Novel, highly selective, muscarinic M3 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1475-1478

Informa Healthcare

Access to resources Recommend Favorite